EPHA3 and lung carcinoma: Current evidence indicated that EPHA3 was closely associated with immune cell infiltration and the efficacy of immunotherapy in tumors such as lung cancer and bladder cancer, suggesting that EPHA3 may play a role in regulating immunogenicity and the immune microenvironment (59).